Product Information
POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1235 per EA under NDC 31722012901. Its NADAC has been published 283 times since May 5, 2021.
FDA first approved this application on Feb 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 meq/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722012901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214420FDA Approved
2/5/2021
TE Code
AB
On Market Since
2/15/2021
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 283 times since May 5, 2021, and over the history we have for it it has declined 74.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1235 per EA |
|---|---|
| All-time high | $0.7407 (Sep 15, 2021) |
| All-time low | $0.1064 (May 22, 2024) |
| 52-week high | $0.1419 |
| 52-week low | $0.1217 |
| Median price | $0.1736 |
| Average price | $0.2595 |
| Largest weekly change | +79.1% (Jan 18, 2023) |
| Weeks tracked | 283 |
| Tracking since | May 5, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Citrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Camber Pharmaceuticals Inc., is $0.1235 per EA (NDC 31722012901), effective Sep 30, 2026.
How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 74.5%. It has been tracked across 283 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?
Since May 5, 2021, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.7407 (Sep 15, 2021), with a median of $0.1736 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 5 MEQ TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?
POTASSIUM CITRATE ER 5 MEQ TAB (NDC 31722012901) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.